Literature DB >> 33242590

Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy.

Katrin Panzitt1, Peter Fickert2, Martin Wagner3.   

Abstract

Autophagy is a lysosomal degradation pathway in which the cell self-digests its own components to provide nutrients in harsh environmental conditions. It also represents an opportunity to rid the cell of superfluous and damaged organelles, misfolded proteins or invaded microorganisms. Liver autophagy contributes to basic hepatic functions such as lipid, glycogen and protein turnover. Deregulated hepatic autophagy has been linked to many liver diseases including alpha-1-antitrypsin deficiency, alcoholic and non-alcoholic fatty liver diseases, hepatitis B and C infections, liver fibrosis as well as liver cancer. Recently, bile acids and the bile acid receptor FXR have been implicated in the regulation of hepatic autophagy, which implies a role of autophagy also for cholestatic liver diseases. This review summarizes the current evidence of bile acid mediated effects on autophagy and how this affects cholestatic liver diseases. Although detailed studies are lacking, we suggest a concept that the activity of autophagy in cholestasis depends on the disease stage, where autophagy may be induced at early stages ("cholestophagy") but may be impaired in prolonged cholestatic states ("cholestopagy").
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Bile acids; Cholestasis; FXR; UDCA

Mesh:

Substances:

Year:  2020        PMID: 33242590     DOI: 10.1016/j.bbadis.2020.166017

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  6 in total

Review 1.  Therapeutic regulation of autophagy in hepatic metabolism.

Authors:  Katherine Byrnes; Sophia Blessinger; Niani Tiaye Bailey; Russell Scaife; Gang Liu; Bilon Khambu
Journal:  Acta Pharm Sin B       Date:  2021-07-28       Impact factor: 11.413

2.  Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies.

Authors:  Adele D'Amico; Antonella Longo; Fabiana Fattori; Michele Tosi; Luca Bosco; Maria Beatrice Chiarini Testa; Maria Giovanna Paglietti; Claudio Cherchi; Adelina Carlesi; Irene Mizzoni; Enrico Bertini
Journal:  Orphanet J Rare Dis       Date:  2021-10-12       Impact factor: 4.123

3.  Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.

Authors:  Hui Zhang; Shu Jia; Lianyu Jin; Jianzuo Yao Mb; Zhihong Shen; Jingyi Wu; Xiaokun Yao; Danwei Chen; Congcong Zhang; Shufang Yu; Ningwei Zhu; Lexiao Jin; Xiaomin Yao
Journal:  Acta Cir Bras       Date:  2022-02-18       Impact factor: 1.388

Review 4.  Transcriptional Regulation of Hepatic Autophagy by Nuclear Receptors.

Authors:  Eun Young Kim; Jae Man Lee
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

5.  FXR deficiency in hepatocytes disrupts the bile acid homeostasis and inhibits autophagy to promote liver injury in Schistosoma japonicum-infected mice.

Authors:  Beibei Zhang; Jing Li; Xianlong Zong; Jianling Wang; Lianlian Xin; Haiyao Song; Wenxue Zhang; Stephane Koda; Hui Hua; Bo Zhang; Qian Yu; Kui-Yang Zheng; Chao Yan
Journal:  PLoS Negl Trop Dis       Date:  2022-08-05

Review 6.  Autophagy in liver diseases: A review.

Authors:  Hui Qian; Xiaojuan Chao; Jessica Williams; Sam Fulte; Tiangang Li; Ling Yang; Wen-Xing Ding
Journal:  Mol Aspects Med       Date:  2021-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.